Back to User profile » Dr Drollmann
Paper published by Dr Drollmann:
Original Research
Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial
Beeh KM, Singh D, Di Scala L, Drollmann A
International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:503-513
Published Date: 31 July 2012